TYW5
tRNA wybutosine-synthesizing protein 5
Also known as: C2orf60, FLJ37953, TYW5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A2RUC4
- Gene
- TYW5
- Ensembl
- ENSG00000162971
- Chromosome
- 2
- Canonical length
- 315 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables several functions, including iron ion binding activity; protein homodimerization activity; and tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity. Involved in wybutosine biosynthetic process. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
315 residues, UniProt reviewed canonical sequence.
>A2RUC4|TYW5
1 MAGQHLPVPR LEGVSREQFM QHLYPQRKPL VLEGIDLGPC TSKWTVDYLS QVGGKKEVKI
61 HVAAVAQMDF ISKNFVYRTL PFDQLVQRAA EEKHKEFFVS EDEKYYLRSL GEDPRKDVAD
121 IRKQFPLLKG DIKFPEFFKE EQFFSSVFRI SSPGLQLWTH YDVMDNLLIQ VTGKKRVVLF
181 SPRDAQYLYL KGTKSEVLNI DNPDLAKYPL FSKARRYECS LEAGDVLFIP ALWFHNVISE
241 EFGVGVNIFW KHLPSECYDK TDTYGNKDPT AASRAAQILD RALKTLAELP EEYRDFYARR
301 MVLHIQDKAY SKNSELocalizationUniProt · AlphaFold · HPA
Whether an antibody against TYW5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 6.5 nTPM
Expression across tissuesHPA
Tissue
- retina: 6.5 nTPM
- cerebellum: 3.7 nTPM
- skin: 3.5 nTPM
- bone marrow: 3.4 nTPM
- liver: 3.2 nTPM
- spleen: 3.2 nTPM
Single-cell type
- müller glia: 73 nCPM
- cone photoreceptor cells: 68 nCPM
- neutrophil progenitors: 62 nCPM
- adrenal cortex cells: 62 nCPM
- neutrophils: 60 nCPM
- sertoli cells: 56 nCPM
Immune cell
- eosinophil: 0.6 nTPM
- basophil: 0.5 nTPM
- memory B-cell: 0.5 nTPM
- naive CD4 T-cell: 0.5 nTPM
- gdT-cell: 0.4 nTPM
- memory CD4 T-cell: 0.4 nTPM
Brain region
- cerebellum: 11 nTPM
- white matter: 9.7 nTPM
- cerebral cortex: 8.3 nTPM
- basal ganglia: 7.7 nTPM
- choroid plexus: 7.5 nTPM
- hippocampal formation: 7.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.24
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.12
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- iron ion binding
- protein homodimerization activity
- tRNA binding
- tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TYW5 as an antibody target. Whether an autoantibody or antibody against TYW5 could matter depends on whether native TYW5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TYW5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TYW5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...